1
Total investments
1
Early stage
0
Mid stage
0
Late stage
6y
Years active
Portfolio
1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Private Investor
Aug 2020
Single-use packaging were born to meet hygienic needs. However, access to cleanliness through disposable plastic is not inevitable! Thanks to a fast-cleaning gesture, auum transforms "single use" by "single move" in order to reuse endlessly.
Auum innovates within the cleaning field through its SmartCleaning concept: a new, fast, convenient & sustainable cleaning technology.
End Single Use Now!
Experience · 5 entries
All (5)
Investments (1)
Founder (1)
2021
Co-founder & CEO
Apr 2021
X-Pressure est dispositif médical innovant pour la mesure automatique et instantanée de la pression du liquide cérébro-spinal (LCS).
La mesure de pression du LCS est historiquement réalisée par l’étude de la colonne deau au bout d’une aiguille de ponction lombaire (PL). Cette mesure est longue, imprécise et ne permet pas de détecter d’éventuelles anomalies. Or, une pression anormale peut avoir des conséquences graves pour le cerveau.
X-Pressure développe un nouveau dispositif médical simple et précis pour mesurer la pression du LCS au lit du patient. Grâce à un système simple et connecté, le médecin peut mesurer la pression au chevet du patient et poser un diagnostic rapidement grâce à la détection automatique des anomalies utilisant lintelligence artificielle.
Notre mission est de permettre une meilleure prise en charge des maladies liées à une pression intracrânienne anormale ou à un trouble de la circulation du LCS, en particulier l’hydrocéphalie responsable de la perte dautonomie chez les personnes âgées.
---
X-Pressure is an innovative medical device for automatic and instantaneous measurement of crebrospinal fluid (CSF).
The measurement of CSF pressure has historically been carried out by studying the water column manometer at the end of a lumbar puncture (LP) needle. This measurement is long, imprecise and unable to detect any anomalies. However, an abnormal CSF pressure can have serious consequences for the brain.
X-Pressure is developing a new easy and precise medical device for measuring CSF pressure at the bedside allowing a quick diagnose thanks to an automatic detection system of abnormalities using artificial intelligence.
Our mission is to allow better management of diseases where ICP or CSF dynamics are abnormal, in particular hydrocephalus responsible for the loss of autonomy in the elderly.
2020
Private Investor
Aug 2020
Single-use packaging were born to meet hygienic needs. However, access to cleanliness through disposable plastic is not inevitable! Thanks to a fast-cleaning gesture, auum transforms "single use" by "single move" in order to reuse endlessly.
Auum innovates within the cleaning field through its SmartCleaning concept: a new, fast, convenient & sustainable cleaning technology.
End Single Use Now!
2018
Private Equity Analyst
Jun 2018
Founded in 2013 by Clara Gaymard and Gonzague de Blignieres, RAISE is a pioneer in engaged sustainable finance with its investment and innovation platform. We are a mission-driven company with a unique model of sharing success. RAISE has four investment strategies as well as our innovation activites, all connected
by our endowment and philanthropic accelerator.
RAISE Investissement Private Equity mid-cap investment strategy focused on French SMEs.
RAISE Ventures Early stage Venture Capital from preseed to series B.
RAISE REIM Value-add real estate investment strategy targeting assets in Paris.
RAISE Impact Private Equity Impact investment strategy focused on European growth with a purpose.
RaiseLab RaiseLab supports open innovation with a strategic and operational consulting activity.
Domaine La Plume A site for executives and entrepreneurs to inspire, innovate and reflect.
RAISESHERPAS The largest philanthropic accelerator in France dedicated to startups, with more than €60 million to support, finance et network startups.
The RAISE Group is based on a financing mechanism that combines profitability and generosity, since the investment teams donate 50% of their profit-sharing to finance the RAISESHERPAS Endowment Fund.
2017
M&A Analyst
Sep 2017
Established in 2003 by Jean-Marie Messier, Messier & Associés (“MA”) has now become one of the most active French Corporate Finance houses with a very large, international, and recurrent client base.
MA is an advisory house serving large global groups to medium-sized corporates, prominent families as well as a wide range of financial sponsors. MA is also one of the most active firm in France on debt restructuring as well as debt and capital advisory. Since April 2019, MA is entered into a long-term strategic partnership with the Italian bank Mediobanca SpA.
The Company is headquartered in Paris, with offices in New-York and employs approx. 40 professionals.
Driven by an entrepreneurial spirit, its high-caliber team builds on the experience and international relationships of its partners to advise and execute on average 30 to 40 transactions a year.
****
Candidatures stages : recrutement@messier-associes.com
Candidatures à létude : Juillet - Septembre 25
2015
Equity Funds Buy-Side Analyst
Apr 2015
L’activité d’Amplegest repose sur trois métiers qui ont tous connu une progression importante depuis sa création en 2007 : la Gestion Privée, le Family Office et la Gestion d’Actifs.
Depuis plus de dix ans, grâce à une croissance organique régulière et à une croissance externe maîtrisée, Amplegest a intégré le club très fermé des sociétés de gestion entrepreneuriales avec 2,34 milliards d’euros d’encours. Le 18 octobre 2018, Amplegest annonçait la prise de participation dans OCTO
Asset Management, spécialiste du marché obligataire et de la dette corporate. Parallèlement à ce développement financier, Amplegest a mis en place une activité philanthropique importante avec le 3 fois 1 % (dons financiers, chantiers de solidarité et mécénat de compétence), qui fait désormais partie intégrante de son ADN.
Rendez-vous sur www.amplegest.com et sur Twitter @amplegest
